European Association for the Study of Diabetes - EASD

European Association for the Study of Diabetes (EASD) — Annual Meeting (Conference Overview)

The European Association for the Study of Diabetes (EASD) Annual Meeting is one of the most important scientific and clinical gatherings for diabetes research and diabetes care in Europe, bringing together investigators, clinicians, healthcare professionals, and industry partners. Based on the official page content we reviewed, the event is communicated as: “Join us in Milan”.

Event Basics (from official content)

• Event name: European Association for the Study of Diabetes – EASD (Annual Meeting)
• City / Country: Milan, Italy (explicitly stated: “Join us in Milan…”)
• Date: Not stated in the provided official text (leave blank rather than guessing)
• Venue (specific congress/arena name): Not stated in the provided official text (leave blank rather than guessing)
• Core theme: “diabetes science and care” with research updates and key discussions shaping future diabetes research and patient care

1️⃣ Who attends (BUYERS / ATTENDEES)

This is not a typical “consumer goods” trade show. It is a medical, scientific, and clinical conference where attendee groups strongly influence what “buyers” look like. For attendee-list or outreach purposes, the most valuable buyer-style contacts are typically not only exhibitors, but also decision-makers who sponsor research, shape clinical programs, influence adoption pathways, and manage professional education and partnership initiatives.

Likely attendee / buyer-aligned groups include:

• Clinicians and diabetes specialists (endocrinologists, diabetologists, diabetics care teams) who influence clinical adoption and education needs
• Medical affairs and clinical research leadership from pharma/biotech and clinical development organizations
• Research leadership (principal investigators, academic research coordinators) and translational medicine teams
• Diagnostics and medical device stakeholders (in vitro diagnostics, CGM ecosystems, insulin delivery, monitoring, and related technologies)
• Healthcare systems / payer ecosystem representatives and policy-linked stakeholders who are interested in outcomes, evidence, and implementation
• Industry partners and conference sponsors who seek targeted engagement with prescribers, KOLs, and research groups

Best buyer interpretation for our research output: focus on industry roles that (a) sponsor diabetes programs, (b) manage evidence generation, (c) run market access and clinical education, and (d) influence adoption of diabetes therapies, diagnostics, monitoring, and care pathways.

2️⃣ Where the show is happening + attendee geographic origin

Location: Milan, Italy (stated on the official page content: “Join us in Milan…”).

Attendee geographic origin (expected pattern for this type of EASD meeting):

• Strong Europe presence, with particularly high representation across Western, Northern, and Southern European countries due to EASD’s European scope
• Cross-regional international participation, especially from major global diabetes research networks, multinational pharma, and international research institutions
• Practical buyer reach angle: We expect the most dense engagement from companies and attendees with European clinical presence, affiliates, and research collaborations headquartered in or closely operating across Europe

Since the provided official text does not specify percentage breakdowns by country, we keep origin detail as a reliable qualitative expectation rather than inventing numeric shares.

3️⃣ Audience reach (Local / National / Global)

For audience reach, this event should be categorized as Global with a strong European core.

• European-first: EASD is a Europe-centered authority in diabetes study and care, so the strongest attendee density is expected across Europe
• International participation: diabetes research and care are inherently global fields, and multinational organizations often send medical affairs, clinical operations, and market access teams
• Net result: buyers should treat this as a high-impact international medical conference even though it is hosted in Europe

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

Below is a buyer-focused sample list designed for research outreach in diabetes care and the ecosystem around it (pharmaceuticals, insulin/therapy delivery, medical devices, diagnostics, and clinical support platforms). These companies are the kinds of organizations typically aligned with EASD’s scientific and clinical audience.

Buyer Target Table (15–20 samples)

Top “send first” buyer set (practical starting list): Roche Diabetes Care, Sanofi, Novo Nordisk, Eli Lilly and Company, Dexcom, Abbott, Medtronic. These reflect a strong mix of pharma + CGM/monitoring + clinical evidence, which best matches the meeting’s diabetes science and care context.

5️⃣ Job profiles, industries & event type

Best job profiles to target:

• Medical Director / Director of Medical Affairs (Diabetes / Endocrinology)
• Clinical Research Director / Head of Clinical Evidence & Publications
• Therapeutic Area Strategy Lead (Diabetes)
• Clinical Operations & Trial Program Manager
• Head of Market Access / Outcomes & Health Economics Lead
• Clinical Affairs Manager (CGM/Insulin delivery/Diagnostics)
• Director, Clinical Partnerships / Scientific Communications Lead
• Real-World Evidence (RWE) / Data & Analytics Director for diabetes programs

Industries that commonly map well (using the style of industry filtering you requested):

• Pharmaceuticals
• Medical Devices
• Hospital & Health Care
• Biotechnology
• Health, Wellness & Fitness
• Research
• Market Research (when tied to outcomes/evidence)
• Information Technology & Services (for digital health / evidence platforms)
• Professional Training & Coaching (where clinical education programs are managed)

Event type categorization:

• Medical / Scientific conference
• Clinical education and diabetes research dissemination
• Therapeutic area congress (diabetes)
• KOL and professional community engagement

6️⃣ Estimated attendance (expected total footfall)

The official text provided does not include an explicit attendance number. For planning and research framing, we can only provide a non-numeric qualitative estimate:

• This is typically considered a major international medical congress, which generally attracts thousands of professionals (researchers, clinicians, and industry stakeholders)
• The attendee mix often includes both scientific presenters and industry-linked medical education and evidence teams

If you want, we can refine the attendance and footfall estimate once you share the exact EASD 2026 (or relevant edition) page that includes attendance figures, hall size, or official registration totals.

7️⃣ Key focus areas & buyer engagement

Key focus areas (based on the official positioning of “diabetes science and care”):

• Diabetes research updates and translational science
• Diabetes management best practices and guideline-related themes
• Clinical discussions on improving patient outcomes
• Evidence generation (clinical studies, outcomes, and scientific communication)
• Education and dissemination of knowledge for clinicians and researchers

Buyer engagement angles that work for this meeting:

• Medical affairs engagement: reach Directors/Leads responsible for evidence, publications, and congress strategy
• Clinical education engagement: target those overseeing professional education, training content, and conference-led learning
• Outcomes and RWE engagement: connect with teams accountable for health economics, real-world evidence, and payer-facing outcomes
• Technology and diagnostics engagement: for CGM, insulin delivery, lab diagnostics—target clinical affairs and evidence teams

8️⃣ Client-product fit note + request to review the client website (to identify the best buyers)

We can recommend the best buyer list specifically aligned to your client’s requirements, but the official page text we received does not include your client product details. We will need your client website to properly segment buyers (e.g., whether your client sells a device, a software platform, clinical services, diagnostics, or a research tool).

Please share the client website URL. Once we review it, we will:

• Identify which buyer sub-verticals match best (pharma vs. medical devices vs. diagnostics vs. digital health vs. research enablement)
• Prioritize job titles that make sense for that product category
• Remove mismatched industries and replace them with higher-fit accounts for EASD’s diabetes ecosystem
• Return a revised “Top buyer set” and an expanded buyer table (15–20 or more) tailored to the client’s ICP

Important: until we see your client website, any “best buyers” we provide are based on broadly expected sponsor/exhibitor alignment with diabetes science and care.

9️⃣ Final recommendation (quality and best targeting approach)

Is this event a good fit for buyer-focused outreach? Yes—particularly if the client product supports diabetes research, diabetes care delivery, clinical education, evidence generation, monitoring/diagnostics, or health outcomes measurement.

Best buyer segments we recommend collecting for EASD:

• Medical Affairs leadership (Diabetes / Endocrinology)
• Clinical Research and Evidence generation decision-makers
• Clinical Affairs leaders for monitoring technologies, insulin delivery, and diagnostics
• Outcomes / RWE / health economics stakeholders
• Corporate partnership and medical education program managers

Next step: please share the client website. We will then produce a refined buyer shortlist tied to your client’s exact value proposition and the corresponding best job titles for EASD’s audience.